{"id":"NCT01751165","sponsor":"GlaxoSmithKline","briefTitle":"Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older","officialTitle":"Open-label Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged 50 Years or Older","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-03-12","primaryCompletion":"2014-05-22","completion":"2015-04-08","firstPosted":"2012-12-17","resultsPosted":"2017-03-31","lastUpdate":"2018-10-18"},"enrollment":354,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Herpes Zoster"],"interventions":[{"type":"BIOLOGICAL","name":"Herpes zoster vaccine GSK1437173A","otherNames":[]}],"arms":[{"label":"HZ/su-0,2 Group","type":"EXPERIMENTAL"},{"label":"HZ/su-0,6 Group","type":"EXPERIMENTAL"},{"label":"HZ/su-0,12 Group","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the safety and immunogenicity of the GSK Biologicals' HZ vaccine 1437173A administered on either a 0,2-; 0,6- or 0,12-month schedule in adults aged 50 years or above, as the immunogenicity of the HZ vaccine administered at intervals longer than two months is not known.","primaryOutcome":{"measure":"Number of Subjects With Vaccine Response to Anti-glycoprotein E (Anti-gE) Antibodies as Determined by the Enzyme-linked Immunosorbent Assay (ELISA).","timeFrame":"At one month (M1) after Dose 2","effectByArm":[{"arm":"GSK1437173A-0,6 M Group","deltaMin":110,"sd":null},{"arm":"GSK1437173A-0,12 M Group","deltaMin":104,"sd":null}],"pValues":[]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":16},"locations":{"siteCount":4,"countries":["United States","Estonia"]},"refs":{"pmids":["29174683"],"seeAlso":["https://clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":119},"commonTop":["Pain","Fatigue","Myalgia","Erythema","Headache"]}}